is diarrhea a symptom of glp 1 How to Stop from GLP-1 Medications: Comprehensive Guide – PlexusDx Mastering GLP-1 Stomach Injections |

In Apr26, Axsome has entered into an asset purchase agreement with Takeda for TAK-063 (balipodect), with an intention to develop it for treating schizophrenia & Tourette syndrome (P-III study-enabling activities for schizophrenia to begin in 2026) Total Revenue: $29.44B Founded Year: 1987 Total Employees: 17,000 Headquarters: California, United States Market Cap: $176.37B Stock Exchange: NASDAQ Gilead is a global biopharma company focused on antivirals and specialty therapeutics, with leadership in HIV, oncology, and liver diseases anchored by a strong antiviral franchise and an expanding oncology portfolio

Chen W, Wainer J, Ryoo SW, Qi X, Chang R, Li J, et al

IL-23 is a cytokine involved in the inflammatory process and is considered to be associated with various chronic immune-mediated diseases

Prausnitz MR, Langer R

In contrast, Bydureon is a long-acting, once-weekly formulation, developed using a microsphere-based delivery system

Common GLP-1 side effects often include nausea, constipation, diarrhea, vomiting, reflux, abdominal discomfort, reduced appetite, and fatigue